Blended Learning, briefly stated, is the well-thought-out combination of complementary and mutually reinforcing online and face-to-face activities, which can lead to an increase in learning efficiency and student motivation. At the same time, Blended Learning can also bring about cost reductions. The successful implementation of Blended Learning requires craftsmanship when it comes to facilitating interactions between management, teachers and students.
Blended Learning is particularly suitable for entrepreneurship education with its emphasis on entrepreneurs’ need for autonomy, and where the construction of knowledge is highly context-dependent.
Here you can watch videos containing the reactions of some of the Blended Learning pilot participants. A few teachers reflect on their redesigned Blended Learning courses while students explain how they experienced this novel educational method.
Be part of the Blended Learning Pilot community
In the Entrepreneurship Blended Learning Pilot Community (EBLPC), visitors can peruse all assignments where participating teachers reflect on analysing, (re)designing, developing, executing and evaluating their course. Watch the video to learn more about the structure of this Blended Learning community, including lessons learned and best practices.
Is it possible to create a cup of coffee that’s healthy and tasty? At the entrepreneurship laboratory Demonstrator Lab at the Vrije Universiteit, Florian Fermin (27) and Stefan Wateler (26) developed Cuppelement, a Fairtrade biodegradable coffee capsule with added superfoods and vitamins. During the Dutch TV program Dragons Den, the entrepreneurs successfully persuaded the dragons […]News
Optics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]News
Azafaros B.V. announced today that the first cohort of healthy subjects has been dosed in a two-part Phase 1 clinical study with clinical candidate AZ-3102, a first-in-class small molecule compound being developed for the treatment of rare neurogenetic disorders. This double-blind, placebo-controlled, Phase 1 study is evaluating the safety and tolerability of ascending single- (SAD) […]News